ORCHARD THERAPEUTICS PLC Earnings Per Share, Basic and Diluted
ORCHARD THERAPEUTICS PLC reported Earnings Per Share, Basic and Diluted of -$0.35 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-12
- ORCHARD THERAPEUTICS PLC earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.35.
- ORCHARD THERAPEUTICS PLC earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$290.00.
- ORCHARD THERAPEUTICS PLC earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$290.00.
- ORCHARD THERAPEUTICS PLC earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.31.
- ORCHARD THERAPEUTICS PLC earnings per share, basic and diluted for fiscal 2021 was -$1.17.
- ORCHARD THERAPEUTICS PLC earnings per share, basic and diluted for fiscal 2020 was -$1.53.
- ORCHARD THERAPEUTICS PLC earnings per share, basic and diluted for fiscal 2019 was -$1.75.
- ORCHARD THERAPEUTICS PLC earnings per share, basic and diluted for fiscal 2018 was -$10.22.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|---|---|
| 2022-03-31 | -$0.35 10-Q · filed 2022-05-12 | ||||||
| 2021-12-31 | -$1.17 10-K · filed 2022-03-30 | ||||||
| 2021-09-30 | -$290.00 10-Q · filed 2021-11-04 | -$880.00 10-Q · filed 2021-11-04 | |||||
| 2021-06-30 | -$290.00 10-Q · filed 2021-08-04 | -$600.00 10-Q · filed 2021-08-04 | |||||
| 2021-03-31 | -$0.31 10-Q · filed 2022-05-12 | ||||||
| 2020-12-31 | -$0.34 10-K · filed 2021-03-02 | -$1.53 10-K · filed 2022-03-30 | |||||
| 2020-09-30 | -$200.00 10-Q · filed 2021-11-04 | -$0.20 10-Q · filed 2020-11-03 | -$1190.00 10-Q · filed 2021-11-04 | -$1.19 10-Q · filed 2020-11-03 | |||
| 2020-06-30 | -$480.00 10-Q · filed 2021-08-04 | -$0.48 10-Q · filed 2020-08-06 | -$990.00 10-Q · filed 2021-08-04 | -$0.99 10-Q · filed 2020-08-06 | |||
| 2020-03-31 | -$0.51 10-Q · filed 2021-05-13 | ||||||
| 2019-12-31 | -$0.46 10-K · filed 2021-03-02 | -$0.84 derived: net income ÷ weighted average shares · filed 2021-03-02 | -$1.39 derived: net income ÷ weighted average shares · filed 2021-03-02 | -$1.75 10-K · filed 2021-03-02 | |||
| 2019-09-30 | -$0.38 10-K · filed 2021-03-02 | -$0.93 derived: net income ÷ weighted average shares · filed 2021-03-02 | -$1.29 10-Q · filed 2020-11-03 | -$1.71 derived: net income ÷ weighted average shares · filed 2021-03-02 | |||
| 2019-06-30 | -$0.56 10-K · filed 2021-03-02 | -$0.92 10-Q · filed 2020-08-06 | -$1.35 derived: net income ÷ weighted average shares · filed 2021-03-02 | -$2.28 derived: net income ÷ weighted average shares · filed 2021-03-02 | |||
| 2019-03-31 | -$0.35 10-K · filed 2021-03-02 | -$0.76 derived: net income ÷ weighted average shares · filed 2021-03-02 | -$1.72 derived: net income ÷ weighted average shares · filed 2021-03-02 | -$5.90 derived: net income ÷ weighted average shares · filed 2021-03-02 | |||
| 2018-12-31 | -$0.42 10-K · filed 2020-02-27 | -$1.69 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$8.09 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$10.22 10-K · filed 2020-02-27 | |||
| 2018-09-30 | -$3.29 10-K · filed 2020-02-27 | -$18.63 derived: net income ÷ weighted average shares · filed 2020-02-27 | -$20.27 6-K · filed 2019-11-07 | ||||
| 2018-06-30 | -$15.45 10-K · filed 2020-02-27 | -$16.99 6-K · filed 2019-08-08 | |||||
| 2018-03-31 | -$1.53 10-K · filed 2020-02-27 | ||||||
| 2017-12-31 | -$4.48 10-K · filed 2020-02-27 | ||||||
| 2016-12-31 | -$2.69 20-F · filed 2019-03-22 |